Management of del(5q) MDS

被引：1
|
作者：
Giagounidis, A. [1 ]
机构：
[1] St Johannes Hosp, Duisburg, Germany
来源：
LEUKEMIA RESEARCH | 2009年 / 33卷
关键词：
D O I：
10.1016/S0145-2126(09)70035-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [41] The IPSS-R has prognostic impact in untreated patients with MDS del(5q)
    Kaivers, J.
    Lauseker, M.
    Hildebrandt, B.
    Fenaux, P.
    Pfeilstoecker, M.
    Valent, P.
    Platzbecker, U.
    Latagliata, R.
    Oliva, E. N.
    Xicoy, B.
    Goetze, K.
    Ganster, C.
    Haase, D.
    Bug, G.
    Kuendgen, A.
    Gattermann, N.
    Haas, R.
    Germing, U.
    LEUKEMIA RESEARCH, 2018, 72 : 27 - 33
  • [42] MDS with del(5q) and associated cKIT D816V positive mastocytosis
    Chan, Noel
    Tan, Shuh Ying
    Opat, Stephen
    Shortt, Jake
    PATHOLOGY, 2012, 44 (05) : 492 - 493
  • [43] Use of Lenalidomide in DEL(5q) MDS. a National AIFA (Agenzia Italiana del Farmaco) Registry Study
    Arcioni, Francesco
    Roncadori, Andrea
    Di Battista, Valeria
    Alimena, Giuliana
    Pane, Fabrizio
    Rossi, Giuseppe
    Buccisano, Francesco
    D'Emilio, Anna
    Di Renzo, Nicola
    Leoni, Pietro
    Caocci, Giovanni
    Rambaldi, Alessandro
    Avanzini, Paolo
    Visani, Giuseppe
    Tura, Sante
    Covezzoli, Anna
    Mecucci, Cristina
    BLOOD, 2015, 126 (23)
  • [44] Molecular characterization of deletions of the long arm of chromosome 5 (del(5q)) in 94 MDS/AML patients
    Douet-Guilbert, N.
    De Braekeleer, E.
    Basinko, A.
    Herry, A.
    Gueganic, N.
    Bovo, C.
    Trillet, K.
    Dos Santos, A.
    Le Bris, M. J.
    Morel, F.
    Eveillard, J. R.
    Berthou, C.
    De Braekeleer, M.
    LEUKEMIA, 2012, 26 (07) : 1695 - 1697
  • [45] Molecular characterization of deletions of the long arm of chromosome 5 (del(5q)) in 94 MDS/AML patients
    N Douet-Guilbert
    E De Braekeleer
    A Basinko
    A Herry
    N Gueganic
    C Bovo
    K Trillet
    A Dos Santos
    M J Le Bris
    F Morel
    J R Eveillard
    C Berthou
    M De Braekeleer
    Leukemia, 2012, 26 : 1695 - 1697
  • [46] Del(5q): gene dosage matters
    Walter, Matthew J.
    BLOOD, 2007, 110 (02) : 473 - 474
  • [47] DBA, del(5q): a reciprocal relationship
    Ellis, Steven R.
    BLOOD, 2011, 118 (08) : 2032 - 2033
  • [48] MYELODYSPLASTIC SYNDROME WITH DEL(5Q) AND LENALIDOMIDE
    Gritsaev, S. V.
    Martinkevitch, I. S.
    Petrova, E. V.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2013, 58 (02): : 3 - 10
  • [49] Lenalidomide in AML: Del(5q) or who?
    Steensma, David P.
    Stone, Richard M.
    BLOOD, 2011, 118 (03) : 481 - 482
  • [50] Survival, prognostic factors, and leukemic transformation in a multicenter study of 241 patients with MDS and del(5q)
    Germing, U.
    Hildebrandt, B.
    Symeonidis, A.
    Cermak, J.
    Pfeilstoecker, M.
    Noesslinger, T.
    Sekkeres, M.
    Maciejewski, J.
    Haase, D.
    Schlenk, R.
    Schanz, J.
    Seymour, J.
    Kenealy, M.
    Koeppler, H.
    Luebbert, M.
    Platzbecker, U.
    Valent, P.
    Blum, S.
    Ottmann, O.
    Goetze, K.
    Stauder, R.
    Kreuzer, K. A.
    Aul, C.
    Kuendgen, A.
    Giagounidis, A.
    LEUKEMIA RESEARCH, 2009, 33 : S74 - S74
12345